These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7555198)

  • 1. Antithrombotic therapy in patients undergoing coronary angioplasty.
    Popma JJ; Coller BS; Ohman EM; Bittl JA; Weitz J; Kuntz RE; Leon MB
    Chest; 1995 Oct; 108(4 Suppl):486S-501S. PubMed ID: 7555198
    [No Abstract]   [Full Text] [Related]  

  • 2. Antithrombotic therapy in patients undergoing percutaneous coronary intervention.
    Popma JJ; Ohman EM; Weitz J; Lincoff AM; Harrington RA; Berger P
    Chest; 2001 Jan; 119(1 Suppl):321S-336S. PubMed ID: 11157657
    [No Abstract]   [Full Text] [Related]  

  • 3. Antithrombotic therapy in patients undergoing coronary angioplasty.
    Popma JJ; Weitz J; Bittl JA; Ohman EM; Kuntz RE; Lansky AJ; King SB
    Chest; 1998 Nov; 114(5 Suppl):728S-741S. PubMed ID: 9822074
    [No Abstract]   [Full Text] [Related]  

  • 4. Platelet activation and coronary interventions.
    Kutryk MJ; Serruys PW
    Eur Heart J; 1996 Aug; 17(8):1134-6. PubMed ID: 8869848
    [No Abstract]   [Full Text] [Related]  

  • 5. Ischemic coronary syndromes and SVG Interventions--do 2b/3a inhibitors miss the target?
    Topaz O
    Catheter Cardiovasc Interv; 2007 Apr; 69(5):630-1. PubMed ID: 17377986
    [No Abstract]   [Full Text] [Related]  

  • 6. Advances in percutaneous coronary intervention in patients with chronic kidney disease.
    Coats WC; Dellsperger KC
    Adv Perit Dial; 2010; 26():42-6. PubMed ID: 21348378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trials of restenosis after coronary angioplasty.
    Popma JJ; Califf RM; Topol EJ
    Circulation; 1991 Sep; 84(3):1426-36. PubMed ID: 1884465
    [No Abstract]   [Full Text] [Related]  

  • 8. Diminishing impact of in-lab complications.
    Tommaso CL; Bergelson BA
    Cathet Cardiovasc Diagn; 1997 Nov; 42(3):257-8. PubMed ID: 9367095
    [No Abstract]   [Full Text] [Related]  

  • 9. Adjunctive pharmacologic therapy in percutaneous coronary intervention: part I antiplatelet therapy.
    Kim SJ; Giugliano RP; Jang IK
    Coron Artery Dis; 2011 Mar; 22(1):100-12. PubMed ID: 20926950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous coronary interventions in patients with renal insufficiency: a high-risk, under-studied cohort.
    Steinhubl SR
    Am Heart J; 2003 Aug; 146(2):213-4. PubMed ID: 12891186
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antithrombotic treatment in acute coronary syndrome].
    Darius H; Rupprecht HJ; Genth-Zotz S; Wittlinger T; Zotz R
    Dtsch Med Wochenschr; 2014 Jan; 139 Suppl 1():S17-22. PubMed ID: 24446037
    [No Abstract]   [Full Text] [Related]  

  • 12. Preventing coronary restenosis and complications.
    Holmes DR
    N Engl J Med; 1997 Jun; 336(24):1748-9. PubMed ID: 9180094
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antithrombotic therapy during percutaneous coronary interventions].
    Verheugt FW; Dieker H; Aengevaeren WR
    Ned Tijdschr Geneeskd; 2005 Apr; 149(17):912-6. PubMed ID: 15884403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of restenosis after coronary angioplasty: towards a molecular approach?
    Feldman LJ; Riessen R; Steg PG
    Fundam Clin Pharmacol; 1995; 9(1):8-16. PubMed ID: 7768490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Medical progress exemplified by improvements in the safety coronary angioplasty].
    Metzger JP
    Bull Acad Natl Med; 2012 Oct; 196(7):1361-7; discussion 1367-8. PubMed ID: 23815020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting Investigators.
    Lincoff AM; Califf RM; Moliterno DJ; Ellis SG; Ducas J; Kramer JH; Kleiman NS; Cohen EA; Booth JE; Sapp SK; Cabot CF; Topol EJ
    N Engl J Med; 1999 Jul; 341(5):319-27. PubMed ID: 10423466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antithrombotic treatment with the coronary stent].
    Hereu P; Agustí A
    Med Clin (Barc); 2000 Jan; 114(3):113-4. PubMed ID: 10736800
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of a synthetic pentasaccharide, a pure factor Xa inhibitor, as an antithrombotic agent--a pilot study in the setting of coronary angioplasty.
    Vuillemenot A; Schiele F; Meneveau N; Claudel S; Donat F; Fontecave S; Cariou R; Samama MM; Bassand JP
    Thromb Haemost; 1999 Feb; 81(2):214-20. PubMed ID: 10063994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Complication of percutaneous coronary intervention--coronary dissection and acute closure].
    Mitsudo K
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():518-23. PubMed ID: 12735026
    [No Abstract]   [Full Text] [Related]  

  • 20. Combined fibrinolysis using reduced-dose alteplase plus abciximab with immediate rescue angioplasty versus primary angioplasty with adjunct use of abciximab for the treatment of acute myocardial infarction: Asia-Pacific Acute Myocardial Infarction Trial (APAMIT) pilot study.
    Wong A; Mak KH; Chan C; Koh TH; Lau KW; Lim TT; Lim ST; Wong P; Sim LL; Lim YT; Tan HC; Lim YL
    Catheter Cardiovasc Interv; 2004 Aug; 62(4):445-52. PubMed ID: 15274152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.